NEW BRUNSWICK, N.J.,
Jan. 10, 2017 /PRNewswire/
-- The Dr. Paul Janssen Award
for Biomedical Research today opens its 2017 call for nominations.
This prestigious award recognizes individuals whose basic or
clinical discoveries have made, or have the potential to make,
significant contributions toward improving human health.
Nominations will be accepted until February
28, 2017 at www.pauljanssenaward.com for consideration by an
independent selection committee of world-renowned scientists. A
$200,000 cash prize will be awarded
to the scientist or group of scientists receiving the Award.
The Dr. Paul Janssen Award for
Biomedical Research honors Dr. Paul
Janssen (1926-2003), one of the most productive
pharmaceutical scientists of the 20th century. Janssen was
responsible for breakthrough treatments in key disease areas
including pain management, psychiatry, infectious disease and
gastroenterology, and founded Janssen Pharmaceutica, N.V., now part
of the Johnson & Johnson Family of Companies (NYSE: JNJ).
"Dr. Paul devoted his life to making a difference for patients
through scientific innovation," said Paul
Stoffels, M.D., Chief Scientific Officer, Johnson &
Johnson. "It takes creativity, courage and an unwavering commitment
to bring forward new research. That's why we are proud to honor the
legacy of Dr. Paul by recognizing those innovative scientists whose
discoveries help us better understand and, ultimately, solve the
major health issues facing our world today."
In 2016, the Dr. Paul Janssen
Award recognized Dr. Yoshinori
Ohsumi, Ph.D., of the Tokyo Institute of Technology for his
pioneering discoveries concerning the molecular basis of autophagy,
which hold promise for better understanding, preventing and
treating many diseases. Dr. Ohsumi subsequently won the Nobel Prize
for the same work.
"Scientific research is crucial to advancing our understanding
of the mechanisms underlying human health and disease," said
David Julius, Ph.D., Professor and
Chair of the Department of Physiology at the University of California, San Francisco, and Chair
of the 2017 Dr. Paul Janssen Award
selection committee. "The selection committee encourages
nominations of deserving scientists from academia, industry,
government and scientific institutions around the world who
exemplify the leadership and passion of Dr. Paul and whose work
helps to advance science and medicine."
Previous Award winners include:
- 2016 – Yoshinori Ohsumi, Ph.D.,
Nobel Laureate
- 2015 – Bert Vogelstein,
M.D.
- 2014 – Emmanuelle Charpentier,
Ph.D. and Jennifer Doudna,
Ph.D.
- 2013 – David Julius, Ph.D.
- 2012 – Victor Ambros, Ph.D., and
Gary Ruvkun, Ph.D.
- 2011 – Napoleone Ferrara,
M.D.
- 2010 – Anthony S. Fauci, M.D.
and Erik De Clercq, M.D.,
Ph.D.,
- 2009 – Axel Ullrich, Ph.D.
- 2008 – Professor Marc Feldmann,
FMedSci, FAA, FRS, Emeritus Professor and Sir Ravinder Maini, FRCP, FMedSci, FRS
- 2006 – Craig Mello, Ph.D., Nobel
Laureate
To learn more about past Dr. Paul
Janssen Award winners, visit www.pauljanssenaward.com.
The 2017 Dr. Paul Janssen Award
winner will be announced in spring 2017.
About The Dr. Paul Janssen
Award for Biomedical Research
Established by Johnson &
Johnson, The Dr. Paul Janssen Award
salutes the most passionate and creative scientists in basic or
clinical research whose scientific achievements have made, or have
strong potential to make, a measurable impact on human health. The
Award is named after the scientist who founded Janssen
Pharmaceutica, N.V. in 1953. Known to his colleagues as "Dr. Paul,"
Janssen helped save millions of lives through his contribution to
the discovery and development of more than 80 medicines, four of
which remain on the World Health Organization's list of essential
medicines. In 1961, Janssen Pharmaceutica, N.V. joined the Johnson
& Johnson Family of Companies. Janssen's legacy continues to
inspire Johnson & Johnson and its commitment to finding
innovative cures for unmet medical needs. Visit
www.pauljanssenaward.com for more information.
About Johnson & Johnson
Caring for the world, one person at a time, inspires and unites the
people of Johnson & Johnson. We embrace research and
science — bringing innovative ideas, products and services to
advance the health and well-being of people. Our approximately
126,900 employees at more than 250 Johnson & Johnson operating
companies work with partners in health care to touch the lives of
over a billion people every day, throughout the world.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/dr-paul-janssen-award-for-biomedical-research-issues-2017-call-for-nominations-300388406.html
SOURCE Johnson & Johnson